British American Tobacco stock slips as Capital Group trims stake; buyback filing keeps BAT share price in focus

British American Tobacco stock slips as Capital Group trims stake; buyback filing keeps BAT share price in focus

London, Jan 27, 2026, 08:32 GMT — Regular session

British American Tobacco shares slipped 0.2% to 4,299 pence at 0832 GMT, following Monday’s close at 4,308 pence. So far, the stock has fluctuated between 4,287 and 4,311 pence, with roughly 239,000 shares changing hands.

The drift follows a key disclosure revealing that Los Angeles-based The Capital Group Companies cut its voting stake in BAT to 18.869293% from 19.013003%. These filings highlight subtle shifts among major holders—signals traders watch closely for signs of supply and demand when the market is otherwise still.

BAT disclosed another chunk of buybacks under its ongoing programme, acquiring 101,395 ordinary shares on Jan. 23 at prices ranging from 4,295p to 4,339p. The company confirmed it plans to cancel these shares, which will leave 2.18 billion shares outstanding (excluding treasury stock) and roughly 133.0 million held in treasury.

The filings reveal a familiar tug-of-war behind this stock: steady corporate buying balanced by occasional selling from large institutions. Neither side moves the needle daily, but the balance becomes crucial when the market looks for clues on which way to go.

A buyback is simple: the company spends cash to repurchase its own shares, cutting the total share count. This can boost earnings per share and occasionally lift the stock price. Still, it doesn’t address the bigger issue facing the sector—how quickly the move away from cigarettes will drive sustainable growth.

BAT has already signaled investors to expect subdued growth in 2026, citing regulatory pressures and stiff competition in the U.S. vaping sector. Despite this, the company outlined a 1.3 billion pound buyback plan for next year. CEO Tadeu Marroco acknowledged early gains from cracking down on unregulated products but warned, “I’m trying to be cautious for 2026,” noting that roughly 70% of the U.S. vape market remains unregulated. At the time, Rae Maile from Panmure Liberum commented, “This is perhaps not quite what the share price needed.” Reuters

That’s the risk for holders: a stricter regulatory environment, slower growth in vaping and nicotine pouches, or a sharper retreat by major shareholders could overwhelm the steady stream of buybacks. In such a scenario, even small daily disclosures might take on outsized significance.

British American Tobacco is set to release its earnings on Feb. 12, per Investing.com’s earnings calendar. Investors will watch closely for any revisions to the 2026 guidance and updates on the speed of buybacks.

Shan Ahmed Khan

Shan Ahmed Khan is a senior markets reporter at TS2.tech. His coverage ranges from stocks and technology to economic developments across global markets. He worked in investment research and market analysis before becoming a financial journalist and is a graduate of the Lahore University of Management Sciences (LUMS).

US Stock Market Today Updates

AI PORTFOLIO

Top Stock Picks

Today’s highest-ranked model selections.

#1 STRONG BUY

Kodiak Gas Services

NYSE:KGS • Energy infrastructure 88/100 • ★★★★☆
#2 STRONG BUY

Neurocrine Biosciences

NASDAQ:NBIX • Healthcare 87/100 • ★★★★☆
#3 STRONG BUY

Alphabet Class A

NASDAQ:GOOGL • Communication services 85/100 • ★★★★☆
#4 BUY ON WEAKNESS

Applied Materials

NASDAQ:AMAT • Semiconductor equipment 84/100 • ★★★★☆
#5 ACCUMULATE

JPMorgan Chase

NYSE:JPM • Financials 80/100 • ★★★★☆
View full portfolio
Editorial model selection. Not personalised advice.
ImmunityBio stock tumbles after glioblastoma update; what to watch before Monday
Previous Story

ImmunityBio stock tumbles after glioblastoma update; what to watch before Monday

USBC stock jumps in premarket after Uphold, Vast Bank tokenized-deposit deal
Next Story

USBC stock jumps in premarket after Uphold, Vast Bank tokenized-deposit deal